Carisa De Anda

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

Angélica Jayk Bernal, Monica Maria Gomes da Silva, Dany Badibanga Musungaie et al. · New England Journal of Medicine · 2021 · 1.8K citations · Full text

Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections

Philippe Prokocimer, Carisa De Anda, Edward Fang et al. · JAMA · 2013 · 352 citations

Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial

Gregory J. Moran, Edward Fang, G. Ralph Corey et al. · The Lancet Infectious Diseases · 2014 · 301 citations

Antimicrobial Susceptibility, Antibiotics, Skin-structure Infections +8

Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections

Andrew F. Shorr, Thomas P. Lodise, G. Ralph Corey et al. · Antimicrobial Agents and Chemotherapy · 2014 · 140 citations · Full text

Antibiotic Adjuvant, Pharmacotherapy, Antimicrobial Chemotherapy +17

Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19

José Ramón Arribas, Sanjay Bhagani, Suzana M. Lobo et al. · NEJM Evidence · 2021 · 124 citations

Adverse Events, Clinical Infectious Disease, Covid-19 Pandemic +14